The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad

Gujarat Cancer and Research Institute, Ahmedabad presented data of total 840 patients, out of which 775 (90%) were in chronic phase. Complete hematological response (CHR) was seen in 96% of patients and median time to achieve (CHR) was 2 months. Complete cytogenetic response was seen in 36%.

Detalles Bibliográficos
Autor principal: Shah, Sandip A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902622/
https://www.ncbi.nlm.nih.gov/pubmed/24516307
http://dx.doi.org/10.4103/0971-5851.123729
Descripción
Sumario:Gujarat Cancer and Research Institute, Ahmedabad presented data of total 840 patients, out of which 775 (90%) were in chronic phase. Complete hematological response (CHR) was seen in 96% of patients and median time to achieve (CHR) was 2 months. Complete cytogenetic response was seen in 36%.

Ejemplares similares